LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 29.92 84.90 1825 2237 0.8156 0.9155
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 29.92 84.90 105 2237 0.0469 0.0461
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 29.92 84.90 2047 2237 0.9148 0.9626
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 31.62 84.90 133 2449 0.0543 0.0970
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 31.62 84.90 1907 2449 0.7785 0.8994
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 31.62 84.90 114 2449 0.0465 0.0627
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 31.62 84.90 2212 2449 0.9030 0.9584
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 33.32 84.90 171 2722 0.0628 0.1502
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 33.32 84.90 2028 2722 0.7449 0.8857
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 33.32 84.90 133 2722 0.0489 0.0939
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 33.32 84.90 2429 2722 0.8922 0.9549
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 35.03 84.90 198 2991 0.0662 0.1791
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 35.03 84.90 2171 2991 0.7258 0.8791
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 35.03 84.90 177 2991 0.0592 0.1537
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 35.03 84.90 2607 2991 0.8715 0.9472
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.73 84.90 232 3254 0.0713 0.2106
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.73 84.90 2305 3254 0.7083 0.8731
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.73 84.90 199 3254 0.0612 0.1758
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.73 84.90 2850 3254 0.8758 0.9502
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 38.43 84.90 253 3459 0.0731 0.2265
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 38.43 84.90 2532 3459 0.7319 0.8866
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 38.43 84.90 230 3459 0.0665 0.2048
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 38.43 84.90 3107 3459 0.8981 0.9602
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 40.14 84.90 298 3682 0.0809 0.2597
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 40.14 84.90 2711 3682 0.7363 0.8905
MN20160318_Q02
E16